Do patients with neurogenic bladder treated with clean intermittent catheterization need antibacterial prophylaxis?

Background/aim: In this study, we investigated the effectiveness of antibiotic prophylaxis (ABP) with respect to the incidence of symptomatic urinary tract infections (UTIs) and evaluated the development of renal scarring in patients treated with clean intermittent catheterization (CIC). Materials and methods: A total of 22 patients were included in the study. The patients were administered ABP in the first year (the ABP-received period) but not in the second year (the ABP-discontinued period). Results: Twenty-eight of all cultures taken in the ABP-received period (18.2%) and 25 (16.2%) of the ABP-discontinued cultures were considered to be indicative of symptomatic UTIs (P = 0.65). The multiple antibiotic resistance rate of microorganisms in cultures taken during the ABP-discontinued period (47; 30.5%) was lower than that in those taken in the ABP-received period (62; 40.3%), (P = 0.07). There was no difference between the ABP-received and ABP-discontinued periods with respect to the development of new lesions according to dimercaptosuccinic acid results (P = 0.14). Conclusion: Routine ABP usage is not protective against the development of symptomatic UTIs and new lesions in neurogenic bladder patients receiving CIC. Furthermore, the growth of resistant microorganisms increased in the ABP-received period

PDF

___

1. Bauer SB. Neurogenic bladder: ethology and assessment. Pediatr Nephrol 2008; 23: 541-551.
2. Larijani FJ, Moghtaderi M, Hajizadeh N, Assadi F. Preventing kidney injury in children with neurogenic bladder dysfunction. Int J Prev Med 2013; 4: 1359-1364.
3. Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin BH, Montgomerie J, Vickrey BG. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83: 129-138.
4. U.S. National Library of Health. Drug Resistance, Multiple. Bethesda, MD, USA: U.S. National Library of Medicine Medical Subject Headings.
5. Clarke SA, Samuel M, Boddy SA. Are prophylactic antibiotics necessary with clean intermittent catheterization? A randomized controlled trial. J Pediatr Surg 2005; 40: 568-571.
6. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean intermittent catheterization in the treatment of urinary tract disease. J Urol 1972; 107: 458-461.
7. Lapides J, Diokno AC, Lowe BS, Kalish MD. Follow-up on unsterile, intermittent self-catheterization. J Urol 1973; 65: 44-50.
8. Schlager TA, Anderson S, Trudell J, Hendley JO. Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J Pediatr 1998; 132: 704-708.
9. National Institute for Health and Clinical Excellence (NICE). Urinary Tract Infection in Children: Diagnosis, Treatment and Long Term Management. Clinical Guideline 54. London, UK: NICE; 2007.
10. Subcommittee on Urinary Tract Infection, Steering Committee on Quality İmprovement and Management, Roberts KB. Urinary tract infection: Clinical Practise Guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128: 595-610.
11. Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, Hodson EM, Carapetis JR, Cranswick NE, Smith G et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 2009; 361: 1748-1759.
12. Dai B, Liu Y, Jia J, Mei C. Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysis. Arch Dis Child 2010; 95: 499-508.
13. RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 2014; 370: 2367-2376.